Position
Fidelity in Cytek Biosciences, Inc.
Back to the book · All holders of CTKB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $17K$4.37 → $4.43
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 234.1K | $1.18M | — | — | — | 0.0% |
| Q1 2026 | 283.4K | $1.24M | $4.37 | −$159.2K | $215.5K | 0.0% |
| Q2 2026 | 504.4K | $2.23M | $4.43 | $17K | $979K | 0.0% |